Matthew Wiley, the Chief Commercial Officer of BioXcel Therapeutics, is leaving the company effective October 2, 2024, and will receive severance benefits including a pro-rated bonus and salary continuation for nine months, while also providing consulting services at $330 per hour thereafter.